Literature DB >> 8837060

Reduced brain N-acetyl-aspartate in frontal lobes suggests neuronal loss in patients with amyotrophic lateral sclerosis.

M Giroud1, P Walker, D Bernard, M Lemesle, D Martin, N Baudouin, F Brunotte, R Dumas.   

Abstract

We performed proton magnetic resonance spectroscopy (1H-MRS) in three patients with amyotrophic lateral sclerosis (ALS) to evaluate the distribution and extent of cortical neuronal damage as demonstrated by decreased N-acetyl-aspartate (NAA) levels. We examined primary motor (precentral gyrus) and parietal neocortical (superior parietal gyrus) regions. ALS was defined with lower and upper motor neuron signs. Compared with matched healthy controls, ALS patients had a significant decrease in NAA levels in the primary motor cortex (p < 0.001) compared with parietal regions and homologous regions in healthy controls. Two clinical applications can be extracted: first, the upper motor neuron signs present in the ALS, come from a neuronal loss within the primary motor cortex and may explain the frontal syndrome associated with ALS. Second clinical applications of 1H-MRS could include identification of extent of upper motor neuron involvement, aiding diagnosis of syndromes presenting with an ALS-like syndrome.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8837060     DOI: 10.1080/01616412.1996.11740412

Source DB:  PubMed          Journal:  Neurol Res        ISSN: 0161-6412            Impact factor:   2.448


  8 in total

1.  The size distribution of neurons in the motor cortex in amyotrophic lateral sclerosis.

Authors:  Mette Helene Toft; Ole Gredal; Bente Pakkenberg
Journal:  J Anat       Date:  2005-10       Impact factor: 2.610

Review 2.  N-acetylaspartate as a marker of neuronal injury in neurodegenerative disease.

Authors:  Norbert Schuff; Dieter J Meyerhoff; Susanne Mueller; Linda Chao; Diana Truran Sacrey; Kenneth Laxer; Michael W Weiner
Journal:  Adv Exp Med Biol       Date:  2006       Impact factor: 2.622

3.  Early detection and longitudinal changes in amyotrophic lateral sclerosis by (1)H MRSI.

Authors:  J Suhy; R G Miller; R Rule; N Schuff; J Licht; V Dronsky; D Gelinas; A A Maudsley; M W Weiner
Journal:  Neurology       Date:  2002-03-12       Impact factor: 9.910

4.  Proton magnetic resonance spectroscopy in patients with early stages of amyotrophic lateral sclerosis.

Authors:  Stefan Sivák; Michal Bittšanský; Egon Kurča; Monika Turčanová-Koprušáková; Milan Grofik; Vladimír Nosál'; Hubert Poláček; Dušan Dobrota
Journal:  Neuroradiology       Date:  2010-04-06       Impact factor: 2.804

Review 5.  Amyotrophic lateral sclerosis: objective upper motor neuron markers.

Authors:  Petra Kaufmann; Hiroshi Mitsumoto
Journal:  Curr Neurol Neurosci Rep       Date:  2002-01       Impact factor: 5.081

6.  Reduced NAA in motor and non-motor brain regions in amyotrophic lateral sclerosis: a cross-sectional and longitudinal study.

Authors:  R R Rule; J Suhy; N Schuff; D F Gelinas; R G Miller; M W Weiner
Journal:  Amyotroph Lateral Scler Other Motor Neuron Disord       Date:  2004-09

Review 7.  Imaging Biomarkers for the Diagnosis and Prognosis of Neurodegenerative Diseases. The Example of Amyotrophic Lateral Sclerosis.

Authors:  Miguel Mazón; Juan Francisco Vázquez Costa; Amadeo Ten-Esteve; Luis Martí-Bonmatí
Journal:  Front Neurosci       Date:  2018-10-25       Impact factor: 4.677

8.  Metabolite profiles correlate closely with neurobehavioral function in experimental spinal cord injury in rats.

Authors:  Yusuke Fujieda; Shinya Ueno; Ryoko Ogino; Mariko Kuroda; Thomas J Jönsson; Lining Guo; Takeshi Bamba; Eiichiro Fukusaki
Journal:  PLoS One       Date:  2012-08-13       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.